Håvard Jørgensen: "This means that fish farmers can still choose feed from BioMar’s product portfolio that promotes growth and health during smoltification and transfer to seawater." Photo: BioMar.

Bid to block sale of BioMar’s Intro Tuning rejected

Fish health products provider STIM has suffered a second defeat in its fight to ban the sale of feed producer BioMar’s Intro Tuning product, which it says violates a new European patent it has for its SuperSmolt system which improves the consistency of smoltification under constant light.

Published Modified

The Oslo County Court concluded just before Christmas 2020 that BioMar’s smoltification feed Intro Tuning does not infringe STIM’s patent, which was granted in the summer of 2020, and therefore rejected STIM’s demand that a ban be placed on the sale of Intro Tuning.

STIM, formerly Europharma, appealed this decision to the Borgarting Court of Appeal, which reconsidered the case and rejected the appeal on Monday. The production and sales of BioMar’s Intro Tuning remain unaffected.

“Even though the outcome of the appeal was as expected, we are very happy that the Court of Appeal has now confirmed that the County Court decision was correct. This means that fish farmers can still choose feed from BioMar’s product portfolio that promotes growth and health during smoltification and transfer to seawater,” said Håvard Jørgensen, managing director of BioMar Norway.